On CNBC’s “Halftime Report Final Trades,” Jenny Harrington of Gilman Hill Asset Management said Sabra Health Care REIT Inc (NASDAQ:SBRA) has an 8.5% yield and “a really terrific management team.” She added, “I think they’re just getting back on stable footing. So, now is the time to buy it.”
Rob Sechan of New Edge Capital Group said Eli Lilly and Co’s (NYSE:LLY) fundamentals are “great” and that the company has “low debt, high cash, 30% operating margins, healthy free cash flow.” He added that the company is “best in class” and that “it’s going to be a great stock.”
